Quantcast

Latest H5N1 clinical trials Stories

2009-10-16 11:00:00

SAYRE, Pa., Oct. 16 /PRNewswire-USNewswire/ -- The Sayre Area School District in Bradford County today became the first Pennsylvania school district to begin administering Novel H1N1 influenza vaccine to its student population, the Department of Health announced. The department also reminded all parents that immunizations play a significant role in keeping children healthy. "The H1N1 virus is disproportionately affecting school-aged children, with almost two-thirds of all cases in...

2009-10-15 08:46:06

Veterinary scientists have made a discovery that promises to deliver a new approach to fast development of cheap vaccines that are effective in all mammals "“ not just humans or another particular species. They propose that by harnessing the system that reads the biological "Ëœbarcodes' of infectious microbes such as food poisoning bacteria, flu viruses and protozoa that cause malaria, one vaccine could be made to prevent a particular disease in all mammals. The research is...

d87e676093a6c7cd8667883edfa4b14a1
2009-10-14 15:35:00

French drugmaker Sanofi-Aventis announced Wednesday that children under the age of 10 may need to get vaccinated twice in order to be protected against the H1N1 swine flu. The announcement falls in line with recommendations from health officials for children in the same age bracket to receive a two-dose regimen in order to protect against the seasonal flu. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told the Associated Press that just one dose of...

2009-10-14 08:01:00

SWIFTWATER, Pa., Oct. 14 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today an interim analysis of data from clinical trials of the U.S. licensed Influenza A (H1N1) 2009 Monovalent Vaccine in infants and children 6 months through 9 years of age. The data indicate the vaccine is immunogenic and that one dose may protect many children. However, the study suggests that two doses of vaccine will be required for...

2009-10-13 07:00:00

BOXMEER, Netherlands, Oct. 13 /PRNewswire-FirstCall/ -- Nobilon, the human vaccine business unit of Schering-Plough Corporation (NYSE: SGP), today announced that it has initiated a clinical Proof of Concept trial with SCH 900795, a new intranasal Live Attenuated Influenza Vaccine (LAIV) for annual seasonal use. "We are encouraged by the continuation of the clinical development program of SCH 900795 after interim results of Nobilon's first ever Phase I study had demonstrated that the...

a5e214d21cde9871bba83b41691d0d39
2009-10-12 12:50:00

A World Health Organization official said Monday that about 100 developing countries would receive international donations of swine flu vaccines, maybe as soon as November, AFP reported. Marie-Paule Kieny, who heads the WHO's vaccine research unit, said the director general of WHO will approve a list of countries for the donations. She told journalists the list will include about 100 countries and they are trying to have the first deliveries in November. Pharmaceutical companies and a US-led...

2009-10-06 17:36:00

HARRISBURG, Pa., Oct. 6 /PRNewswire-USNewswire/ -- Pre-registered and certified providers in the southwest, southeast, and north-central regions of the state have begun to receive the first doses of the live attenuated pandemic H1N1 influenza vaccine, also known by the brand name FluMist, the Pennsylvania Department of Health said today. This vaccine, which comes as a nasal spray, is recommended primarily for healthy persons between the ages of 2-49 years of age. It is not indicated...

2009-10-01 11:08:00

LYON, France and SWIFTWATER, Pa., Oct. 1 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today an interim analysis of data from clinical trials of the U.S. licensed Influenza A (H1N1) 2009 Monovalent Vaccine in adults 18 years through 64 years of age and over the age of 65 years. These data indicate that a single 15 mcg dose of Sanofi Pasteur's Influenza A (H1N1) 2009 Monovalent Vaccine, administered to adults,...

2009-09-30 10:22:00

HARRISBURG, Pa., Sept. 30 /PRNewswire-USNewswire/ -- The Pennsylvania Department of Health today discussed the state's distribution plans for the new pandemic H1N1 vaccine. Pennsylvania is placing its first vaccine order today. Due to the limited nature of the initial vaccine supplies, the doses will be highly focused in their distribution and use. More than 70 percent of all illness from the pandemic H1N1 flu virus is occurring in Pennsylvania's children and young adults aged five to...

a09cd1217ea4e362ec838d21fbc68bb71
2009-09-22 11:50:42

Early results from a trial of H1N1 influenza vaccine in children shows the vaccine appears to be as effective as in the trial in adults, U.S. researchers said. Officials at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, said the preliminary analysis of blood samples from a small group of trial participants showed a single 15-microgram dose of a non-adjuvanted H1N1 vaccine generates an immune response expected to be protective against in...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related